Faldaprevir and Deleobuvir for HCV Genotype 1 Infection von Zeuzem, Stefan, Soriano, Vincent, Asselah, Tarik, Bronowicki, Jean-Pierre, Lohse, Ansgar W, Müllhaupt, Beat, Schuchmann, Marcus, Bourlière, Marc, Buti, Maria, Roberts, Stuart K, Gane, Ed J, Stern, Jerry O, Vinisko, Richard, Kukolj, George, Gallivan, John-Paul, Böcher, Wulf-Otto, Mensa, Federico J

Volltext

Restoration of HCV-specific CD8+ T cell function by interferon-free therapy von Martin, Bianca, Hennecke, Nadine, Lohmann, Volker, Kayser, Antonin, Neumann-Haefelin, Christoph, Kukolj, George, Böcher, Wulf-Otto, Thimme, Robert

Volltext

Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans von Tubic, Marija, Wagner, Daniel, Spahn-Langguth, Hildegard, Weiler, Christine, Wanitschke, Roland, Böcher, Wulf Otto, Langguth, Peter

Volltext

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection von ZEUZEM, Stefan, SORIANO, Vincent, GANE, Ed J, STERN, Jerry O, VINISKO, Richard, KUKOLJ, George, GALLIVAN, John-Paul, BÖCHER, Wulf-Otto, MENSA, Federico J, ASSELAH, Tarik, BRONOWICKI, Jean-Pierre, LOHSE, Ansgar W, MÜLLHAUPT, Beat, SCHUCHMANN, Marcus, BOURLIERE, Marc, BUTI, Maria, ROBERTS, Stuart K

Volltext

SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients von DIETERICH, Douglas, ASSELAH, Tarik, STERN, Jerry O, OZAN, Melek, DATSENKO, Yakov, BÖCHER, Wulf Otto, STEINMANN, Gerhard, GUYADER, Dominique, BERG, Thomas, SCHUCHMANN, Marcus, MAUSS, Stefan, RATZIU, Vlad, FERENCI, Peter, LARREY, Dominique, MAIERON, Andreas

Volltext

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants von FitzSimons, David, François, Guido, Hall, Andrew, McMahon, Brian, Meheus, André, Zanetti, Alessandro, Duval, Bernard, Jilg, Wolfgang, Böcher, Wulf Otto, Lu, Sheng-Nan, Akarca, Ulus, Lavanchy, Daniel, Goldstein, Susan, Banatvala, Jangu, Damme, Pierre Van

Volltext

Faldaprevir and deleobuvir for HCV genotype 1 infection von Zeuzem, Stefan, Soriano, Vincent, Asselah, Tarik, Bronowicki, Jean-Pierre, Lohse, Ansgar W, Müllhaupt, Beat, Schuchmann, Marcus, Bourlière, Marc, Buti, Maria, Roberts, Stuart K, Gane, Ed J, Stern, Jerry O, Vinisko, Richard, Kukolj, George, Gallivan, John-Paul, Böcher, Wulf-Otto, Mensa, Federico J

Volltext

Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results von Zeuzem, Stefan, Asselah, Tarik, Angus, Peter, Zarski, Jean-Pierre, Larrey, Dominique, Müllhaupt, Beat, Gane, Ed, Schuchmann, Marcus, Lohse, Ansgar, Pol, Stanislas, Bronowicki, Jean-Pierre, Roberts, Stuart, Arastéh, Keikawus, Zoulim, Fabien, Heim, Markus, Stern, Jerry O, Nehmiz, Gerhard, Kukolj, George, Böcher, Wulf Otto, Mensa, Federico J

Volltext

Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interf... von Böcher, Wulf Otto, Herzog‐Hauff, Sabine, Schlaak, Jörg, Meyer zum Büschenfelde, Karl‐Hermann, Löhr, Hanns Friedrich

Volltext

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trim... von Böcher, Wulf Otto, Galun, Eithan, Marcus, Hadar, Daudi, Nili, Terkieltaub, Dov, Shouval, Daniel, Löhr, Hanns Friedrich, Reisner, Yair

Volltext

ITPA genotypes predict anemia but do not affect virological response with interferon-free faldaprevir, deleobuvir, and ribavirin for hcv infection

Volltext bestellen

Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation von Zimmermann, Tim, Böcher, Wulf O, Biesterfeld, Stefan, Zimmermann, Anca, Kanzler, Stefan, Greif-Higer, Gertrud, Barreiros, Ana Paula, Sprinzl, Martin F, Wörns, Marcus A, Lohse, Ansgar W, Mönch, Christian, Otto, Gerd, Galle, Peter R, Schuchmann, Marcus

Volltext

Efficacy of an escalating dose regimen of pegylated interferon α‐2a plus ribavirin in the early phase of HCV reinfection after liver transplantation von Zimmermann, Tim, Böcher, Wulf O., Biesterfeld, Stefan, Zimmermann, Anca, Kanzler, Stefan, Greif‐Higer, Gertrud, Barreiros, Ana Paula, Sprinzl, Martin F., Wörns, Marcus A., Lohse, Ansgar W., Mönch, Christian, Otto, Gerd, Galle, Peter R., Schuchmann, Marcus

Volltext

Efficacy of an escalating dose regimen of pegylated interferon ?-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation von Zimmermann, Tim, Böcher, Wulf O., Biesterfeld, Stefan, Zimmermann, Anca, Kanzler, Stefan, Greif-Higer, Gertrud, Barreiros, Ana Paula, Sprinzl, Martin F., Wörns, Marcus A., Lohse, Ansgar W., Mönch, Christian, Otto, Gerd, Galle, Peter R., Schuchmann, Marcus

Volltext